Analysis of Revenues
Paying user area
Try for free
Walgreens Boots Alliance Inc. pages available for free this week:
- Income Statement
- Statement of Comprehensive Income
- Common-Size Balance Sheet: Assets
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Liquidity Ratios
- Analysis of Reportable Segments
- Analysis of Geographic Areas
- Enterprise Value to EBITDA (EV/EBITDA)
- Operating Profit Margin since 2005
- Return on Assets (ROA) since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Walgreens Boots Alliance Inc. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Revenues as Reported
Walgreens Boots Alliance Inc., income statement, revenues
US$ in millions
Based on: 10-K (reporting date: 2019-08-31), 10-K (reporting date: 2018-08-31), 10-K (reporting date: 2017-08-31), 10-K (reporting date: 2016-08-31), 10-K (reporting date: 2015-08-31), 10-K (reporting date: 2014-08-31).
- Overall Revenue Trend
- The total sales revenue exhibited a consistent upward trend over the three-year period from 2017 to 2019. Sales increased from $118,214 million in 2017 to $136,866 million in 2019, indicating a growth momentum in the company's overall business operations.
- Retail Pharmacy USA
- The Retail Pharmacy USA segment showed strong growth each year between 2017 and 2019. Revenue increased from $87,302 million in 2017 to $104,532 million in 2019, reflecting steady expansion and possibly increased market share within the United States. This segment constitutes the largest share of revenue within the retail pharmacy operations.
- Pharmacy and Retail Segments
- The Pharmacy segment experienced significant revenue growth from 2017 ($60,607 million) to 2019 ($77,192 million). The Retail segment revenues remained relatively stable, with a slight increase from 2017 ($26,695 million) to 2018 ($27,337 million) followed by a plateau at $27,340 million in 2019. This suggests the pharmacy services contributed more heavily to revenue growth compared to retail sales.
- Retail Pharmacy International
- Revenues from the Retail Pharmacy International segment show slight fluctuation with a modest decline from $12,281 million in 2018 to $11,462 million in 2019. This indicates some challenges or market contractions internationally during the last reported year.
- Pharmaceutical Wholesale
- The Pharmaceutical Wholesale division revenue increased from $21,188 million in 2017 to $23,053 million in 2019. This steady increase signals an expanding wholesale business that is contributing positively to the company’s revenue base.
- Pharmacy within Retail Pharmacy International
- Pharmacy-specific revenue within the Retail Pharmacy International segment declined in 2019 to $4,080 million from $4,360 million in 2018, potentially reflecting competitive pressures or reduced demand in these markets.
- Retail within Retail Pharmacy International
- Retail revenue within the international segment decreased from $7,921 million in 2018 to $7,382 million in 2019, further emphasizing the overall downturn in international retail pharmacy sales.
- Eliminations
- The data shows consistent eliminations in inter-segment transactions, increasing marginally from -$2,089 million in 2017 to -$2,181 million in 2019. This reflects internal offsets to consolidated revenue, maintaining a stable proportion relative to total sales.